Access Issues, Cancer Drug Parity Act, Safe Step Act
2025 · 4th Quarter (Oct 1 - Dec 31)
INTERNATIONAL MYELOMA FOUNDATION
Filed by INTERNATIONAL MYELOMA FOUNDATION.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Amendment
- Posted
- Apr 23, 2026
- Income
- Not reported
- Expenses
- $23,005.00
- Registrant
- INTERNATIONAL MYELOMA FOUNDATION
- Filing UUID
- 0c2f14ac-d979-4067-ac80-ab3c055d8db6
- Termination date
- Not reported
Expense method: B
Literal source text
Lobbying issues and bill citations
CDMRP's PRCRP
H.R. 9747, (P.L. 118-83) the FY2025 Continuing Appropriations and Extensions Act: Cancer Research, Appropriations: Cancer Research, NIH, CDC, NCI, DoD, ARPA-H
Literal federal measure citations: H.R. 9747
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.